Objectives This systematic review aimed to comprehensively collect and summarise the
current body of knowledge regarding the cost-of-illness of amyotrophic lateral sclerosis, to …

This systematic review comprises an objective appraisal of the evidence in regard to the
management of respiration in patients with motor neuron disease (MND/ALS). Studies were …

Background Several studies have identified occupational exposure to extremely low-
frequency electromagnetic fields (EMF) as a potential risk factor for neurodegenerative …

Sarcopenia is the term widely used to describe the progressive loss of muscle mass with
advancing age. Even before significant muscle wasting becomes apparent, ageing is …

Given their capacity to regenerate cells lost through injury or disease, stem cells offer new
vistas into possible treatments for degenerative diseases and their underlying causes. As …

Our objective was to estimate the economic burden of patients with amyotrophic lateral
sclerosis (ALS) and to examine the effect of treatment in a multidisciplinary ALS treatment …

Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

Background Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder.
Consequently, patients undergo a multidisciplinary treatment that often requires intensive …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that imposes a
great burden on the patient, the patient's family and society. However, we lack information …

Introduction: Amyotrophic lateral sclerosis (ALS) is a devastating illness of unclear etiology
affecting motor neurons. It causes unremitting muscle paralysis, atrophy and death usually …